table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Transdermal and Transmucosal Drug Delivery Market Size Analysis from 2023 to 2028
1.5.1 Global Transdermal and Transmucosal Drug Delivery Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Transdermal and Transmucosal Drug Delivery Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Transdermal and Transmucosal Drug Delivery Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Transdermal and Transmucosal Drug Delivery Industry Impact
Chapter 2 Global Transdermal and Transmucosal Drug Delivery Competition by Types, Applications, and Top Regions and Countries
2.1 Global Transdermal and Transmucosal Drug Delivery (Volume and Value) by Type
2.1.1 Global Transdermal and Transmucosal Drug Delivery Consumption and Market Share by Type (2017-2022)
2.1.2 Global Transdermal and Transmucosal Drug Delivery Revenue and Market Share by Type (2017-2022)
2.2 Global Transdermal and Transmucosal Drug Delivery (Volume and Value) by Application
2.2.1 Global Transdermal and Transmucosal Drug Delivery Consumption and Market Share by Application (2017-2022)
2.2.2 Global Transdermal and Transmucosal Drug Delivery Revenue and Market Share by Application (2017-2022)
2.3 Global Transdermal and Transmucosal Drug Delivery (Volume and Value) by Regions
2.3.1 Global Transdermal and Transmucosal Drug Delivery Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Transdermal and Transmucosal Drug Delivery Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Transdermal and Transmucosal Drug Delivery Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Transdermal and Transmucosal Drug Delivery Consumption by Regions (2017-2022)
4.2 North America Transdermal and Transmucosal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Transdermal and Transmucosal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Transdermal and Transmucosal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Transdermal and Transmucosal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Transdermal and Transmucosal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Transdermal and Transmucosal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Transdermal and Transmucosal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Transdermal and Transmucosal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
4.10 South America Transdermal and Transmucosal Drug Delivery Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Transdermal and Transmucosal Drug Delivery Market Analysis
5.1 North America Transdermal and Transmucosal Drug Delivery Consumption and Value Analysis
5.1.1 North America Transdermal and Transmucosal Drug Delivery Market Under COVID-19
5.2 North America Transdermal and Transmucosal Drug Delivery Consumption Volume by Types
5.3 North America Transdermal and Transmucosal Drug Delivery Consumption Structure by Application
5.4 North America Transdermal and Transmucosal Drug Delivery Consumption by Top Countries
5.4.1 United States Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
5.4.2 Canada Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
5.4.3 Mexico Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 6 East Asia Transdermal and Transmucosal Drug Delivery Market Analysis
6.1 East Asia Transdermal and Transmucosal Drug Delivery Consumption and Value Analysis
6.1.1 East Asia Transdermal and Transmucosal Drug Delivery Market Under COVID-19
6.2 East Asia Transdermal and Transmucosal Drug Delivery Consumption Volume by Types
6.3 East Asia Transdermal and Transmucosal Drug Delivery Consumption Structure by Application
6.4 East Asia Transdermal and Transmucosal Drug Delivery Consumption by Top Countries
6.4.1 China Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
6.4.2 Japan Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
6.4.3 South Korea Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 7 Europe Transdermal and Transmucosal Drug Delivery Market Analysis
7.1 Europe Transdermal and Transmucosal Drug Delivery Consumption and Value Analysis
7.1.1 Europe Transdermal and Transmucosal Drug Delivery Market Under COVID-19
7.2 Europe Transdermal and Transmucosal Drug Delivery Consumption Volume by Types
7.3 Europe Transdermal and Transmucosal Drug Delivery Consumption Structure by Application
7.4 Europe Transdermal and Transmucosal Drug Delivery Consumption by Top Countries
7.4.1 Germany Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
7.4.2 UK Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
7.4.3 France Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
7.4.4 Italy Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
7.4.5 Russia Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
7.4.6 Spain Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
7.4.7 Netherlands Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
7.4.8 Switzerland Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
7.4.9 Poland Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 8 South Asia Transdermal and Transmucosal Drug Delivery Market Analysis
8.1 South Asia Transdermal and Transmucosal Drug Delivery Consumption and Value Analysis
8.1.1 South Asia Transdermal and Transmucosal Drug Delivery Market Under COVID-19
8.2 South Asia Transdermal and Transmucosal Drug Delivery Consumption Volume by Types
8.3 South Asia Transdermal and Transmucosal Drug Delivery Consumption Structure by Application
8.4 South Asia Transdermal and Transmucosal Drug Delivery Consumption by Top Countries
8.4.1 India Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
8.4.2 Pakistan Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Transdermal and Transmucosal Drug Delivery Market Analysis
9.1 Southeast Asia Transdermal and Transmucosal Drug Delivery Consumption and Value Analysis
9.1.1 Southeast Asia Transdermal and Transmucosal Drug Delivery Market Under COVID-19
9.2 Southeast Asia Transdermal and Transmucosal Drug Delivery Consumption Volume by Types
9.3 Southeast Asia Transdermal and Transmucosal Drug Delivery Consumption Structure by Application
9.4 Southeast Asia Transdermal and Transmucosal Drug Delivery Consumption by Top Countries
9.4.1 Indonesia Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
9.4.2 Thailand Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
9.4.3 Singapore Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
9.4.4 Malaysia Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
9.4.5 Philippines Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
9.4.6 Vietnam Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
9.4.7 Myanmar Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 10 Middle East Transdermal and Transmucosal Drug Delivery Market Analysis
10.1 Middle East Transdermal and Transmucosal Drug Delivery Consumption and Value Analysis
10.1.1 Middle East Transdermal and Transmucosal Drug Delivery Market Under COVID-19
10.2 Middle East Transdermal and Transmucosal Drug Delivery Consumption Volume by Types
10.3 Middle East Transdermal and Transmucosal Drug Delivery Consumption Structure by Application
10.4 Middle East Transdermal and Transmucosal Drug Delivery Consumption by Top Countries
10.4.1 Turkey Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
10.4.3 Iran Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
10.4.5 Israel Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
10.4.6 Iraq Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
10.4.7 Qatar Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
10.4.8 Kuwait Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
10.4.9 Oman Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 11 Africa Transdermal and Transmucosal Drug Delivery Market Analysis
11.1 Africa Transdermal and Transmucosal Drug Delivery Consumption and Value Analysis
11.1.1 Africa Transdermal and Transmucosal Drug Delivery Market Under COVID-19
11.2 Africa Transdermal and Transmucosal Drug Delivery Consumption Volume by Types
11.3 Africa Transdermal and Transmucosal Drug Delivery Consumption Structure by Application
11.4 Africa Transdermal and Transmucosal Drug Delivery Consumption by Top Countries
11.4.1 Nigeria Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
11.4.2 South Africa Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
11.4.3 Egypt Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
11.4.4 Algeria Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
11.4.5 Morocco Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 12 Oceania Transdermal and Transmucosal Drug Delivery Market Analysis
12.1 Oceania Transdermal and Transmucosal Drug Delivery Consumption and Value Analysis
12.2 Oceania Transdermal and Transmucosal Drug Delivery Consumption Volume by Types
12.3 Oceania Transdermal and Transmucosal Drug Delivery Consumption Structure by Application
12.4 Oceania Transdermal and Transmucosal Drug Delivery Consumption by Top Countries
12.4.1 Australia Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
12.4.2 New Zealand Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 13 South America Transdermal and Transmucosal Drug Delivery Market Analysis
13.1 South America Transdermal and Transmucosal Drug Delivery Consumption and Value Analysis
13.1.1 South America Transdermal and Transmucosal Drug Delivery Market Under COVID-19
13.2 South America Transdermal and Transmucosal Drug Delivery Consumption Volume by Types
13.3 South America Transdermal and Transmucosal Drug Delivery Consumption Structure by Application
13.4 South America Transdermal and Transmucosal Drug Delivery Consumption Volume by Major Countries
13.4.1 Brazil Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
13.4.2 Argentina Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
13.4.3 Columbia Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
13.4.4 Chile Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
13.4.5 Venezuela Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
13.4.6 Peru Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
13.4.8 Ecuador Transdermal and Transmucosal Drug Delivery Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Transdermal and Transmucosal Drug Delivery Business
14.1 3M
14.1.1 3M Company Profile
14.1.2 3M Transdermal and Transmucosal Drug Delivery Product Specification
14.1.3 3M Transdermal and Transmucosal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Antares Pharma
14.2.1 Antares Pharma Company Profile
14.2.2 Antares Pharma Transdermal and Transmucosal Drug Delivery Product Specification
14.2.3 Antares Pharma Transdermal and Transmucosal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Aveva Drug Delivery Systems
14.3.1 Aveva Drug Delivery Systems Company Profile
14.3.2 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Product Specification
14.3.3 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Corium International
14.4.1 Corium International Company Profile
14.4.2 Corium International Transdermal and Transmucosal Drug Delivery Product Specification
14.4.3 Corium International Transdermal and Transmucosal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 DURECT
14.5.1 DURECT Company Profile
14.5.2 DURECT Transdermal and Transmucosal Drug Delivery Product Specification
14.5.3 DURECT Transdermal and Transmucosal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Pantec Biosolutions
14.6.1 Pantec Biosolutions Company Profile
14.6.2 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Product Specification
14.6.3 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Tapemark
14.7.1 Tapemark Company Profile
14.7.2 Tapemark Transdermal and Transmucosal Drug Delivery Product Specification
14.7.3 Tapemark Transdermal and Transmucosal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Tesa Labtec
14.8.1 Tesa Labtec Company Profile
14.8.2 Tesa Labtec Transdermal and Transmucosal Drug Delivery Product Specification
14.8.3 Tesa Labtec Transdermal and Transmucosal Drug Delivery Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Transdermal and Transmucosal Drug Delivery Market Forecast (2023-2028)
15.1 Global Transdermal and Transmucosal Drug Delivery Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Transdermal and Transmucosal Drug Delivery Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Transdermal and Transmucosal Drug Delivery Value and Growth Rate Forecast (2023-2028)
15.2 Global Transdermal and Transmucosal Drug Delivery Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Transdermal and Transmucosal Drug Delivery Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Transdermal and Transmucosal Drug Delivery Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Transdermal and Transmucosal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Transdermal and Transmucosal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Transdermal and Transmucosal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Transdermal and Transmucosal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Transdermal and Transmucosal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Transdermal and Transmucosal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Transdermal and Transmucosal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Transdermal and Transmucosal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Transdermal and Transmucosal Drug Delivery Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Transdermal and Transmucosal Drug Delivery Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Transdermal and Transmucosal Drug Delivery Consumption Forecast by Type (2023-2028)
15.3.2 Global Transdermal and Transmucosal Drug Delivery Revenue Forecast by Type (2023-2028)
15.3.3 Global Transdermal and Transmucosal Drug Delivery Price Forecast by Type (2023-2028)
15.4 Global Transdermal and Transmucosal Drug Delivery Consumption Volume Forecast by Application (2023-2028)
15.5 Transdermal and Transmucosal Drug Delivery Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
